Spursex
Alert Team
Before I ask this, I'm going to emphasis that I am not an anti-vaxer and I encourage those to please get it when they get the option to do so.
But does anyone know (or able to point me to an article on this) why the UK regulator has been able to approve this vaccine but the equivalents in other countries/regions haven't done so yet? I'm thinking mostly in terms of the US and EU regulators. You would image they would have a relatively similar approach to some degree in terms of how they review the trial data and what they expect from it. I presume each of these regulators have got access to the same data by now and so is there something that these bodies are questioning that the UK didn't think was a concern? And before we get the sort of response we've heard in the last few days of "my da is better than your da", has there been any actual explanation of why the UK's da is the dog's bollocks?
ALL have access to the same data. The UK didn't follow the EU mandated approach to trials; instead it choose to assess all data all stages as the trials collated them - so in short by dropping the protocol the EU rigidly enforces across all members the UK's regulatory agency was able to be 'final data ready' and thus in a position to make a quick go/stop decision about each and every vaccine.
The US also (said they didn't have the manpower also followed the standard protocols.
It really was a question of approach, as so many drug discovery trials are conducted here now, we were ready for it.
It has probably bought the UK a one month lead on the analysis; which, by the way it has now shared via the WHO to any country in the World who wants to see it.